J Drugs Dermatol. 2020 Aug 1;19(8):788-792. doi: 10.36849/JDD.2020.5079.
Melasma is a chronic dermatologic condition with an incompletely understood pathogenesis and well-demonstrated impact on patient quality of life. Melasma is a common cause for seeking dermatologic care, and with no universally efficacious therapy or cure, com-bination treatment is the best approach for many cases. Numerous studies have demonstrated the role of oxidative stress in patients with melasma, prompting investigation into several antioxidants for melasma therapy. In this review, we discuss the well-defined role of oxidative stress in melasma and the therapeutic efficacy of various antioxidants for patients suffering from melasma. We focus our discussion on studies investigating the role of vitamin C, azelaic acid, cysteamine, glutathione, carotenoids, and numerous other antioxidants in disorders of hyperpigmentation. There is promising evidence for the use of these antioxidants, as topical, oral, and intra-venous preparations, both in isolation and in conjunction with other melasma therapies. J Drugs Dermatol. 2020;19(8):788-792. doi:10.36849/JDD.2020.5079.
黄褐斑是一种慢性皮肤病,其发病机制尚未完全阐明,对患者的生活质量有明显影响。黄褐斑是寻求皮肤科治疗的常见原因,由于目前尚无普遍有效的治疗方法或治愈方法,因此联合治疗是许多病例的最佳方法。许多研究表明氧化应激在黄褐斑患者中起作用,这促使人们研究了几种抗氧化剂用于治疗黄褐斑。在这篇综述中,我们讨论了氧化应激在黄褐斑中的明确作用,以及各种抗氧化剂对黄褐斑患者的治疗效果。我们的讨论重点是研究维生素 C、壬二酸、半胱氨酸、谷胱甘肽、类胡萝卜素和许多其他抗氧化剂在色素沉着过度疾病中的作用。有有希望的证据表明,这些抗氧化剂无论是单独使用还是与其他黄褐斑疗法联合使用,无论是局部、口服还是静脉制剂,都可用于治疗黄褐斑。《皮肤病药物杂志》。2020;19(8):788-792.doi:10.36849/JDD.2020.5079.